Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | -0.74% | 33.50 | 0.9% | $1136.55m | |
| JNJ | Johnson & Johnson | -0.37% | 142.74 | 0.7% | $1075.07m | |
| BMY | Bristol-Myers Squibb Co. | -2.36% | 58.16 | 1.0% | $944.64m | |
| MRK | Merck & Co., Inc. | -1.45% | 76.79 | 0.7% | $804.84m | |
| ABBV | AbbVie, Inc. | -1.53% | 97.76 | 2.3% | $772.99m | |
| LLY | Eli Lilly & Co. | -1.57% | 166.48 | 1.1% | $685.12m | |
| VXRT | Vaxart, Inc. | 1.35% | 8.26 | 0.0% | $290.34m | |
| AZN | AstraZeneca Plc | -0.33% | 54.01 | 1.2% | $289.11m | |
| RPRX | Royalty Pharma Plc | 0.02% | 48.03 | 0.1% | $226.55m | |
| NVS | Novartis AG | -0.76% | 87.45 | 0.2% | $150.36m | |
| RGEN | Repligen Corp. | 2.82% | 128.82 | 7.2% | $120.54m | |
| GSK | GlaxoSmithKline Plc | -0.91% | 40.36 | 0.2% | $111.43m | |
| NVO | Novo Nordisk A/S | -0.56% | 65.51 | 0.1% | $93.67m | |
| RETA | Reata Pharmaceuticals, Inc. | -0.73% | 156.85 | 3.4% | $81.53m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | -2.05% | 76.35 | 0.0% | $71.79m |
Company Profile
Oncternal Therapeutics, Inc. is a clinical-stage oncology company, which develops a diverse pipeline of treatments for cancers with critically unmet medical need. It focuses on drug development of untapped biological pathways implicated in cancer progression. The company was founded by David F. Hale and James B. Breitmeyer in 1997 and is headquartered in San Diego, CA.